ARLINGTON, Texas — Notable developments in the North Texas healthcare landscape include prestigious national rankings for local hospitals and key leadership appointments at a major Arlington facility.
Forbes has released its inaugural “Top Hospitals in America” ratings, awarding top marks to several DFW institutions. Additionally, USMD Hospital at Arlington has strengthened its executive team with two new C-Suite additions. See the comprehensive state rankings here.
Forbes Ranks North Texas Hospitals
In its first-ever comprehensive quality ranking, Forbes awarded five-star overall ratings to Baylor Scott & White Health – Irving and JPS Health Network.
Several other area hospitals received distinguished four-star ratings, including:
- Baylor Scott & White: Fort Worth, Grapevine, and Waxahachie locations.
- Texas Health: Alliance, Southwest Fort Worth, Dallas, and Denton locations.
The rankings utilize continuously refreshed data from Inovalon to provide patients with transparent insights into hospital performance and peer comparisons.
New C-Suite Leaders at USMD Hospital at Arlington
USMD Hospital at Arlington is moving forward with a refreshed leadership team, announcing two significant internal promotions.
- Jamie Bentley has been named the new Chief Nursing Officer (CNO). Bentley previously served as the hospital’s vice president of patient services for two years.
- Lydia Ameka returns to the facility as the new Chief Operating Officer (COO). Ameka, who previously worked at the hospital from 2007 to 2022 as vice president of operations, brings over a decade of institutional knowledge back to the role.
“These promotions reflect our confidence in Jaime and Lydia’s ability to lead with integrity and inspire excellence,” stated Joe Minissale, interim CEO of USMD Hospital at Arlington. “Their leadership, alongside Tonya Smith’s financial expertise, will ensure we remain at the forefront of patient care and satisfaction.”
Grants Fuel Cancer Research & Prevention
In other regional healthcare news, the Mary Kay Ash Foundation has awarded a $500,000 grant to the Baylor Scott & White Dallas Foundation.
- Focus: The funding supports a clinical trial on triple-negative breast cancer, an aggressive form resistant to hormone therapies.
- Specifics: $100,000 is dedicated to a trial led by Dr. Joyce O’Shaughnessy exploring whether weight-loss medications can reduce recurrence risks in overweight patients. The remainder funds the Texas Cancer Interception Institute to advance early detection.
Additionally, the Cancer Prevention Initiative (CPI) and Lyda Hill Philanthropies have opened a new funding round featuring a $750,000 matching challenge. This initiative aims to accelerate the development of vaccines and prevention drugs for hereditary cancers.
